Effect of C-Reactive Protein–Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative BacteremiaElodie von Dach, Angela Huttner, Shawna McCallin et al.|JAMA|2020Cited by 255
PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemiaAngela Huttner, Laurent Kaiser, Werner C. Albrich et al.|BMJ Open|2017Cited by 11
How representative is a point-of-care randomized trial? Clinical outcomes of patients excluded from a point-of-care randomized controlled trial evaluating antibiotic duration for Gram-negative bacteraemia: a multicentre prospective observational cohort studyAnne Rossel, Angela Huttner, Kimberly P.M. Zandberg et al.|Clinical Microbiology and Infection|2021Cited by 9
Isavuconazole for the Treatment of Fungal Infections: A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS)Jade Couchepin, Laura N. Walti, Ilana Reinhold et al.|Open Forum Infectious Diseases|2024Cited by 8
Validation of IDSA/ATS Algorithm for Duration of Pneumonia TherapyWerner C. Albrich, Angela Huttner, Benedikt Huttner|JAMA Internal Medicine|2017Cited by 0